文献速递腹部USCT

超声造影增强模式鉴别实性胰腺病变的临床价值

Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions.
PubMed 文献 · Eur Radiol · 2021-10-30

该研究纳入210例有明确病理或临床诊断的实性胰腺病变患者,提出六种超声造影(CEUS)增强模式,评估其鉴别诊断价值并与常规超声及增强CT比较。结果显示两位医师对六种模式判读一致性良好(kappa=0.767),各模式诊断准确率较高,CEUS诊断准确率显著优于常规超声,与增强CT无显著差异。

要点

  • 六种CEUS增强模式可用于实性胰腺病变鉴别,观察者间一致性良好。
  • 低增强或向心性增强诊断胰腺癌准确率87.62%,高增强诊断神经内分泌肿瘤准确率92.89%。
  • 包膜增强诊断实性假乳头状肿瘤准确率97.63%,等增强或等增强伴局灶低增强诊断局灶性胰腺炎准确率89.10%。

核心结论

  • 实性胰腺病变的CEUS增强模式具有临床鉴别价值,诊断准确率高于常规超声且不劣于增强CT。

研究设计与样本

  • 单中心回顾性或前瞻性研究(原文未明确),纳入210例有病理或临床诊断的实性胰腺病变患者。
  • 两位超声医师盲法判读CEUS增强模式,分析观察者间一致性。
  • 比较CEUS与常规超声(210例)及增强CT(146例)的诊断准确率。

关键影像表现/征象

  • 提出六种CEUS增强模式:高增强、等增强、等增强伴局灶低增强、低增强、向心性增强、包膜增强。
  • 低增强或向心性增强提示胰腺癌;高增强提示神经内分泌肿瘤。
  • 包膜增强伴内部低增强或不均匀增强提示实性假乳头状肿瘤;等增强或等增强伴局灶低增强提示局灶性胰腺炎。

诊断标准与关键数值

  • 低增强或向心性增强诊断胰腺癌的准确率为87.62%。
  • 高增强诊断神经内分泌肿瘤的准确率为92.89%。
  • 包膜增强诊断实性假乳头状肿瘤的准确率为97.63%。
  • 等增强或等增强伴局灶低增强诊断局灶性胰腺炎的准确率为89.10%。
  • 两位医师判读六种增强模式的一致性kappa值为0.767。

临床应用与阅片要点

  • 阅片时可依据六种CEUS增强模式对实性胰腺病变进行鉴别诊断。
  • 注意低增强或向心性增强提示胰腺癌,高增强提示神经内分泌肿瘤。
  • 包膜增强提示实性假乳头状肿瘤,等增强或等增强伴局灶低增强提示局灶性胰腺炎。

局限性

  • 增强CT对比仅纳入146例,样本量少于CEUS组。
  • 原文未明确研究设计类型(回顾性或前瞻性)及是否单中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore the diagnostic value of contrast-enhanced ultrasound (CEUS) enhancement patterns for differentiating solid pancreatic lesions and compare them with conventional ultrasound (US) and enhanced computed tomography (CT).

METHODS: A total of 210 patients with solid pancreatic lesions who had definite pathological or clinical diagnoses were enrolled. Six CEUS enhancement patterns were proposed for solid pancreatic lesions. Two US doctors blindly observed the CEUS patterns of solid pancreatic lesions and the interrater agreement was analyzed. The diagnostic value of CEUS enhancement patterns for differentiating solid pancreatic lesions was evaluated, and the diagnostic accuracy was compared with that of US and enhanced CT.

RESULTS: There was good concordance for six CEUS enhancement patterns of solid pancreatic lesions between the two doctors, with a kappa value of 0.767. Hypo-enhancement (Hypo-E) or centripetal enhancement (Centri-E) as the diagnostic criteria for pancreatic carcinoma had an accuracy of 87.62%; hyper-enhancement (Hyper-E) for neuroendocrine tumors had an accuracy of 92.89%; capsular enhancement with low or uneven enhancement inside the tumor (Capsular-E) for solid pseudopapillary tumors had an accuracy of 97.63%; and iso-enhancement (Iso-E) or iso-enhancement with focal hypo-enhancement (Iso-fhypo-E) for focal pancreatitis had an accuracy of 89.10%. The diagnostic accuracy of CEUS was significantly different from that of US for 210 cases of solid pancreatic lesions (p < 0.05) and was not significantly different from that of enhanced CT for 146 cases of solid pancreatic lesions (p > 0.05).

CONCLUSIONS: The different enhancement patterns of solid pancreatic lesions on CEUS were clinically valuable for differentiation.

KEY POINTS: • Six CEUS enhancement (E) patterns, including Hyper-E, Iso-E, Iso-fhypo-E, Hypo-E, Centri-E, and Capsular-E, are proposed for the characterization of solid pancreatic lesions. • Using Hypo-E or Centri-E as the diagnostic criteria for pancreatic carcinoma, Hyper-E for neuroendocrine tumors, Capsular-E for solid pseudopapillary tumors, and Iso-E or Iso-fhypo-E for focal pancreatitis on CEUS had relatively high diagnostic accuracy. • The diagnostic accuracy of CEUS was greatly increased over that of US and was not different from that of enhanced CT.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Li G, Yan K, et al. Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions. Eur Radiol. 2021. PMID: 34716476. doi:10.1007/s00330-021-08243-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。